Insulet (PODD) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.18% |
| Dec 31, 2025 | 11.24% |
| Sep 30, 2025 | 12.11% |
| Jun 30, 2025 | 16.35% |
| Mar 31, 2025 | 25.98% |
| Dec 31, 2024 | 21.99% |
| Sep 30, 2024 | 18.99% |
| Jun 30, 2024 | 24.13% |
| Mar 31, 2024 | 22.46% |
| Dec 31, 2023 | 22.75% |
| Sep 30, 2023 | 22.73% |
| Jun 30, 2023 | 23.25% |
| Mar 31, 2023 | 22.50% |
| Dec 31, 2022 | 22.48% |
| Sep 30, 2022 | 34.06% |
| Jun 30, 2022 | 35.70% |
| Mar 31, 2022 | 35.99% |
| Dec 31, 2021 | 35.02% |
| Sep 30, 2021 | 34.56% |
| Jun 30, 2021 | 48.87% |
| Mar 31, 2021 | 48.50% |
| Dec 31, 2020 | 46.76% |
| Sep 30, 2020 | 42.31% |
| Jun 30, 2020 | 40.19% |
| Mar 31, 2020 | 29.38% |
| Dec 31, 2019 | 30.92% |
| Sep 30, 2019 | 33.32% |
| Jun 30, 2019 | 24.62% |
| Mar 31, 2019 | 26.98% |
| Dec 31, 2018 | 26.39% |
| Sep 30, 2018 | 25.08% |
| Jun 30, 2018 | 24.00% |
| Mar 31, 2018 | 24.19% |
| Dec 31, 2017 | 32.76% |
| Sep 30, 2017 | 19.73% |
| Jun 30, 2017 | 17.66% |
| Mar 31, 2017 | 15.58% |
| Dec 31, 2016 | 15.59% |
| Sep 30, 2016 | 14.69% |
| Jun 30, 2016 | 1.96% |
| Dec 31, 2015 | 11.98% |